Additional file 1 of Preservation of the ovarian reserve and hemostasis during laparoscopic ovarian cystectomy by a hemostatic agent versus suturing for patients with ovarian endometriosis: study protocol for randomized controlled, non-inferiority trial (PRAHA-2 trial)

article OA: green CC0
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

This study protocol outlines the schedule for enrolling patients, administering interventions, and performing assessments for a randomized controlled trial comparing a hemostatic agent to suturing for laparoscopic ovarian cystectomy in patients with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Additional file 1: Table S1. Schedule of enrolment, interventions, and assessments. Abbreviation: AMH, anti-Müllerian hormone. *Initial laboratory test includes complete blood count, liver enzyme, BUN, creatinine, electrolyte, etc. After operation, only complete blood count will be measured on every visit. **Ovarian volume is measured by transvaginal or transrectal ultrasonography.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (22)

Source provenance

openalex
last seen: 2026-05-13T18:34:15.591076+00:00
License: CC0 · commercial use OK